Würzburg
Universitätsklinikum Würzburg
Effects of Tumor Treating Fields (TTFields) on glioblastoma, anaplastic ependymoma and oligodendroglioma samples in a patient-derived ex vivo organoid model
Pharmaceutical Screening in vestibular schwannoma ex vivo tumor slice model
Establishment of a novel ex vivo model for the assessment of Tumor Treating Fields (TTFields) effects on the blood-brain barrier (BBB)
CAR-T cells against three novel antigens show antitumoral efficacy in ex vivo patient derived glioblastoma organoids
A combination of CAR-T cell specificities can overcome antigen escape mechanisms in ex vivo glioblastoma models
Tumormicroenvironment in Vestibular schwannoma with and without NF2
Metastasis associated in colorectal cancer 1 (MACC1) mRNA expression in vestibular schwannoma
Introducing an innovative and time-effective method to generate ex vivo patient-derived glioblastoma organoid models
Co-culture of PBMCs and patient derived organoids enhances glioblastoma tumor microenvironment
Ex vivo glioblastoma organoids reflect tumor microenvironment
Effects of Tumor Treating Fields (TTFields) on glioblastoma, anaplastic ependymoma and oligodendroglioma samples in a patient-derived ex vivo organoid model